These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29626221)

  • 41. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
    Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
    Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52.
    Shao S; Ren C; Liu Z; Bai Y; Chen Z; Wei Z; Wang X; Zhang Z; Xu K
    Int J Biochem Cell Biol; 2017 Nov; 92():43-52. PubMed ID: 28928041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EYK1 encoding erythrulose kinase as a catabolic selectable marker for genome editing in the non-conventional yeast Yarrowia lipolytica.
    Vandermies M; Denies O; Nicaud JM; Fickers P
    J Microbiol Methods; 2017 Aug; 139():161-164. PubMed ID: 28552427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of genome engineering using the CRISPR-Cas9 system in C. glabrata wild-type and lig4 strains.
    Cen Y; Timmermans B; Souffriau B; Thevelein JM; Van Dijck P
    Fungal Genet Biol; 2017 Oct; 107():44-50. PubMed ID: 28822858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A RecET-assisted CRISPR-Cas9 genome editing in Corynebacterium glutamicum.
    Wang B; Hu Q; Zhang Y; Shi R; Chai X; Liu Z; Shang X; Zhang Y; Wen T
    Microb Cell Fact; 2018 Apr; 17(1):63. PubMed ID: 29685154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo.
    Yarrington RM; Verma S; Schwartz S; Trautman JK; Carroll D
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9351-9358. PubMed ID: 30201707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional Reconstitution of a Fungal Natural Product Gene Cluster by Advanced Genome Editing.
    Weber J; Valiante V; Nødvig CS; Mattern DJ; Slotkowski RA; Mortensen UH; Brakhage AA
    ACS Synth Biol; 2017 Jan; 6(1):62-68. PubMed ID: 27611015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic applications of CRISPR/Cas9 system in gene therapy.
    Mollanoori H; Teimourian S
    Biotechnol Lett; 2018 Jun; 40(6):907-914. PubMed ID: 29704220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic Compatibility and Extensibility of Orthogonal Replication.
    Javanpour AA; Liu CC
    ACS Synth Biol; 2019 Jun; 8(6):1249-1256. PubMed ID: 31095905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combinatorial optimization of CRISPR/Cas9 expression enables precision genome engineering in the methylotrophic yeast Pichia pastoris.
    Weninger A; Hatzl AM; Schmid C; Vogl T; Glieder A
    J Biotechnol; 2016 Oct; 235():139-49. PubMed ID: 27015975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent progresses in CRISPR genome editing in plants].
    Li H; Xie K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1700-1711. PubMed ID: 29082718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A two-plasmid inducible CRISPR/Cas9 genome editing tool for Clostridium acetobutylicum.
    Wasels F; Jean-Marie J; Collas F; López-Contreras AM; Lopes Ferreira N
    J Microbiol Methods; 2017 Sep; 140():5-11. PubMed ID: 28610973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Creating functional chromosome fusions in yeast with CRISPR-Cas9.
    Shao Y; Lu N; Xue X; Qin Z
    Nat Protoc; 2019 Aug; 14(8):2521-2545. PubMed ID: 31300803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRISPR/Cas9-mediated Inactivation of arginase in a yeast strain isolated from Nuruk and its impact on the whole genome.
    Chin YW; Shin SC; Han S; Jang HW; Kim HJ
    J Biotechnol; 2021 Nov; 341():163-167. PubMed ID: 34601018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
    Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
    J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Multiplex MoClo Toolkit for Extensive and Flexible Engineering of
    Shaw WM; Khalil AS; Ellis T
    ACS Synth Biol; 2023 Nov; 12(11):3393-3405. PubMed ID: 37930278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro CRISPR-Cas9-mediated efficient Ad5 vector modification.
    Tang L; Gong M; Zhang P
    Biochem Biophys Res Commun; 2016 May; 474(2):395-399. PubMed ID: 27125457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.